Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App Credit Cards
Go PRO Now
Open App
you are here:
Success
Alert
Please select a Day.
Info

Natco Pharma Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
Add to

68/100
833.30
5.20 (0.63%)

As on 30 Oct, 2025 | 03:54

Open Trading A/c
Day Range
824.25
835.60
L H
52 Week Range
726.80
1505.00
L H
Volume
223,669
*
i

* BSE Market Depth (30 Oct 2025)

BUY SELL
QTY PRICE PRICE QTY
299 831.55 833.95 2077
299 831.45 834.00 62
108 831.10 834.30 20
155 831.05 834.40 299
16 830.65 834.50 434
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
68/100
832.50
4.05 (0.49%)

As on 30 Oct, 2025 | 04:01

Open Trading A/c
Day Range
824.40
835.30
L H
52 Week Range
660.05
1504.00
L H
Volume
33,105
*
i

* BSE Market Depth (30 Oct 2025)

BUY SELL
QTY PRICE PRICE QTY
299 831.55 833.95 2077
299 831.45 834.00 62
108 831.10 834.30 20
155 831.05 834.40 299
16 830.65 834.50 434
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
NSE
MC Essentials
65% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, High Growth Trend Stock at Reasonable Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 828.80
          Previous Close 828.10
          Volume 223,669.00
          Value (Lacs) 1,863.83
            VWAP 828.55
          Beta
          Mkt Cap (Rs. Cr.) 14,925
          High 835.60
          Low 824.25
          UC Limit 993.70
          LC Limit 662.50
          52 Week High 1,505.00
          52 Week Low 726.80
          Face Value 2.00
          All Time High 1,639.00
          All Time Low 1.61
          20D Avg Volume 547,831
          20D Avg Delivery(%) 33.84
          Book Value Per Share 424.71
          Dividend Yield 0.72
          TTM EPS See historical trend 94.78 (+3.67% YoY)
          TTM PE See historical trend 8.79 (Low PE)
          P/B See historical trend 1.97 (Low P/B)
          Sector PE 39.83

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          68/100
          Superior Financial Strength, High Growth Trend Stock at Reasonable Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 44.63% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoters decreased holding from 49.56% to 49.48% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          9 out of 17 years Natco Pharma has given negative returns in October.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          October 23.01% (2017) 5.86% -17.85% (2009) -5.44% -0.12%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Natco Pharma

          What's your call on Natco Pharma today?

          Read 8 investor views

          BUY SELL HOLD
          POST

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          24 Apr, 2025

          Graviton Research Capital Llp

          Qty 1784917 Price 930.19 % Traded 1.03
          24 Apr, 2025

          Graviton Research Capital Llp

          Qty 1784917 Price 929.71 % Traded 1.03
          14 Feb, 2025

          Graviton Research Capital Llp

          Qty 971727 Price 890.86 % Traded 0.55
          14 Feb, 2025

          Graviton Research Capital Llp

          Qty 971727 Price 891.03 % Traded 0.55

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Natco Pharma 833.30 0.63 14,925.23 8.79 1.96 24.78 -39.73 1,883 4,429 0.04
          Sun Pharma 1,703.40 -0.73 408,702.72 39.40 5.66 15.13 -8.03 10,980 52,578 0.03
          Divis Labs 6,655.00 2.20 176,669.34 76.61 11.80 14.63 13.05 2,191 9,360 0.00
          Cipla 1,540.10 -2.59 124,403.99 23.07 4.39 16.90 8.59 5,291 27,547 0.00
          Torrent Pharma 3,602.40 0.09 121,921.59 60.90 16.25 25.17 14.81 1,911 11,516 0.40
          + See More

          About the Company

          Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million.It is an India-based company engaged in manufacturing active pharmaceutical ingredients.The Companys segments include bulk chemicals, finished dosage formulations, retail pharmacy and job work charges. The Companys products in the oncology segment include Desifer, Veenat, Bendit, Bortenat, Lenalid and Clokeran. The Companys product offerings in the pharma segment include T-Score, PT-MaX, Glatimer, Tarana and Tigi. The Company operates in India, United States of America, Europe and the rest of the world.
          {"success":1,"data":{"address":{"address1":"NATCO House, Road # 2,","address2":"Banjara Hills,,","city":"Hyderabad","state":"Telangana","pincode":"500034","telephone1":"040-23547532","telephone2":"","fax1":"040-23548243","fax2":"","email":"investors@natcopharma.co.in","web":"http:\/\/www.natcopharma.co.in"},"management":[{"name":"V C Nannapaneni","designation":"Chairman & Managing Director"},{"name":"Rajeev Nannapaneni","designation":"Vice Chairman & CEO"},{"name":"P S R K Prasad","designation":"Director & Exe. VP (Corp. Engg. Services)"},{"name":"D Linga Rao","designation":"Director & President (Tech. Affairs)"},{"name":"D Vijaya Bhaskar","designation":"Independent Director"}],"registrars":{"name":"Venture Capital & Corporate Investments Pvt. Ltd.","address1":"\u201cAurum\u201d, Door No.4-50\/P-II\/57\/4F & 5F, Plot No.57,","address2":"","address3":"","address4":"","telephone":"040-23818475, 23868257, 35164940","fax":"","email":"investor.relations@vccipl.com","internet":"https:\/\/www.vccipl.com","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"524816","nseId":"NATCOPHARM","series":"EQ","isinid":"INE987B01026"}}}

          • Registered Office

          • Registrars

          • Management

            • V C Nannapaneni

              Chairman & Managing Director

            • Rajeev Nannapaneni

              Vice Chairman & CEO

            • P S R K Prasad

              Director & Exe. VP (Corp. Engg. Services)

            • D Linga Rao

              Director & President (Tech. Affairs)

            • D Vijaya Bhaskar

              Independent Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

            • Nifty 200

              No

          • Details

            • BSE:

              524816

            • NSE:

              NATCOPHARM

            • Series

              EQ

            • ISIN

              INE987B01026

          Go to Top
          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347